For the Quarter Ending June 2023

North America

The prices of Oxcarbazepine in North America experienced a downward trend in the second quarter of 2023. Weak demand and high stock levels impacted the market fundamentals, leading to sluggish trading conditions. Domestic sales dropped due to higher inflation, while inquiries from the regional market remained weak. Retailers faced bloated warehouse inventories as they had ordered excessive stock during the pandemic to meet surging demand. Imports at the North American port also declined. Despite strengthening CPI in certain areas, such as the United States, there were no significant changes in local demand, resulting in a negative market trajectory for Oxcarbazepine. Traders and suppliers were reluctant to place future orders as they focused on destocking their existing inventories due to disrupted weather conditions in June.

Asia Pacific

The prices of Oxcarbazepine, an Active Pharmaceutical Ingredient, saw a significant decline throughout the second quarter of 2023 in both regional and overseas markets. Lower consumption in the pharmaceutical and healthcare sectors led to increased stockpiling, causing concern among merchants who focused on destocking. Although India's Purchasing Managers' Index (PMI) showed some improvement, inquiries from the downstream sector remained weak. By the end of Q2, the Indian market settled at USD 118,145.57/MT IP Ex-Vadodara with a month-on-month decrement of 4.20 percent in June 2023. Exports from India decreased for the fifth consecutive month, impacted by the slowdown in major economies like North America and the EU, along with inflationary pressures.



Get Real Time Prices of Oxcarbazepine: https://www.chemanalyst.com/Pricing-data/oxcarbazepine-1528

Europe

Oxcarbazepine prices in Europe followed a similar decline as in the United States throughout the second quarter of 2023. Factors such as lower consumer spending, declining logistical costs, weaker downstream inquiries, and higher stored supplies contributed to this trend. The decline in the Euro's value relative to the USD also added to the negative market sentiment. Traders hesitated to place additional orders due to increasing inventory levels and a lack of strong demand. The decrease in the cost of raw ingredients for Oxcarbazepine further contributed to the price decline. Geopolitical tensions and rising oil costs between Russia and Ukraine disrupted supply chains, impacting economic activity for both consumers and businesses. Prices remained unfriendly in June due to excess supplies and heavy output from big manufacturers, leading downstream businesses to offer Oxcarbazepine at lower prices.


About Us:

ChemAnalyst is an online platform offering a comprehensive range of market analysis and pricing services, as well as up-to-date news and deals from the chemical and petrochemical industry, globally.

Being awarded ‘The Product Innovator of the Year, 2023’, ChemAnalyst is an indispensable tool for navigating the risks of today's ever-changing chemicals market.

The platform helps companies strategize and formulate their chemical procurement by tracking real time prices of more than 400 chemicals in more than 25 countries.

ChemAnalyst also provides market analysis for more than 1000 chemical commodities covering multifaceted parameters including Production, Demand, Supply, Plant Operating Rate, Imports, Exports, and much more. The users will not only be able to analyse historical data but will also get to inspect detailed forecasts for upto 10 years. With access to local field teams, the company provides high-quality, reliable market analysis data for more than 40 countries.